(87 days)
No
The description focuses on standard pulse oximetry technology and communication protocols, with no mention of AI or ML. The calculation method is explicitly stated as identical to a predicate device from 1989.
No
This device is for monitoring oxygen saturation and pulse rate, not for providing therapy.
Yes.
The device monitors oxygen saturation and pulse rate, which are physiological parameters used to assess a patient's health status and aid in diagnosis.
No
The device description explicitly states it is an "APEX OXIMETER" and describes its function in calculating oxygen saturation and generating serial communications. This strongly implies a hardware component (the oximeter itself) is involved in acquiring the physiological data, not just software processing.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "portable patient monitoring of an ambulating patient's oxygen saturation and pulse rate." This involves monitoring physiological parameters directly from the patient's body.
- Device Description: The description reinforces this by stating it's for "portable patient monitoring of an ambulating patient's oxygen saturation and pulse rate."
- Lack of IVD Characteristics: The text does not mention any analysis of biological samples (blood, urine, tissue, etc.) in vitro (outside the body). IVDs are designed to perform tests on these types of samples to diagnose or monitor conditions.
This device is a medical device used for patient monitoring, specifically a pulse oximeter, which measures oxygen saturation and pulse rate non-invasively.
N/A
Intended Use / Indications for Use
This device is viewed as a component of a system. The APEX Oximeter adds modularity to Marquette's CD Telemetry System product line. The Apex Oximeter is intended for portable patient monitoring of an ambulating patient's oxygen saturation and pulse rate.
This device is intended to be used by personnel trained in the use of the equipment. It is intended to be used within the hospital/facility environment.
Product codes
74 DQA
Device Description
This device is viewed as a component of a system. The APEX OXIMETER adds modularity to Marquette's telemetry product line. It is intended for portable patient monitoring of an ambulating patient's oxygen saturation and pulse rate. The oxygen saturation calculations for the Apex Oximeter is performed identically to the method used in the Nonin 8500 series hand held pulse oximeter. The oximeter generates serial communications with a custom protocol to communicate with the CD Telemetry System.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
This device is intended to be used by personnel trained in the use of the equipment. It is intended to be used within the hospital/facility environment.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Various reliability and software testing was performed on the product, and the results indicated that the APEX OXIMETER met the requirements of its intended use. Marquette Medical Systems has demonstrated that use of the APEX OXIMETER is as safe and effective, and performs substantially equivalent its predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Nonin Model 8500 Hand Held Pulse Oximeter (K893221), Nonin Model 9500 Finger Clip Pulse Oximeter (K942248), Marquette CD Telemetry System (K891104)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
KC180299
APR 2 4 1998 510(k) Summary of Safety and Effectiveness
Submitter 1.
Marquette Medical Systems 8200 West Tower Avenue Milwaukee, WI 53223 USA
Establishment Registration Number 2124823
Contact Name / Telephone Number David Wahlig Corporate Regulatory Affairs Marquette Medical Systems
Phone: (414) 362-2090 ·
Date: 26 January 98
2. General Information
Trade/Proprietary Name
Marquette's name for this device is the APEX OXIMETER.
Common/Usual Name
This device is commonly known as pulse oximeter.
Device Classification
This device is viewed as a component of a system. The APEX OXIMETER adds modularity to Marquette's telemetry product line. It is intended for portable patient monitoring of an ambulating patient's oxygen saturation and pulse rate. The oxygen saturation calculations for the Apex Oximeter is performed identically to the method used in the Nonin 8500 series hand held pulse oximeter. The oximeter generates serial communications with a custom protocol to communicate with the CD Telemetry System. Therefore, the submitted device takes on the same classification level as the predicate oximeter.
FDA determined the predicate devices to be: Nonin Model 8500 Hand Held Pulse Oximeter and Nonin Model 9500 Finger Clip Pulse Oximeter were determined to be Class II devices. The CD Telemetry System was determined to be a Class III.
Performance Standards
Performance standards (Section 514 of the Act) have not yet been established for the device that is the subject of this premarket notification submission.
1
Legally Marketed Predicate Device(s) 3.
This submission is being filed as a modification to an existing device. It is being filed in support of the position that the proposed modified device, the APEX OXIMETER, is substantially equivalent to devices already in legal commercial distribution: Nonin Model 8500 Hand Held Pulse Oximeter (K893221); Nonin Model 9500 Finger Clip Pulse Oximeter (K942248); Marquette CD Telemetry System (K891104).
Device Description and Intended Use 4.
This device is viewed as a component of a system. The APEX OXIMETER adds modularity to Marquette's telemetry product line. It is intended for portable patient monitoring of ambulating patient's oxygen saturation and pulse rate. The oxygen saturation calculations for the Apex Oximeter is performed identically to the method used in the Nonin 8500 series hand held pulse oximeter. The oximeter generates serial communications with a custom protocol to communicate with the CD Telemetry System
Test Summary & Conclusion 5.
Various reliability and software testing was performed on the product, and the results indicated that the APEX OXIMETER met the requirements of its intended use. Marquette Medical Systems has demonstrated that use of the APEX OXIMETER is as safe and effective, and performs substantially equivalent its predicate devices.
0000006
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure, with three curved lines representing its wings or body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the bird-like figure.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 2 4 1998
Mr. David Wahliq Marquette Medical Systems, Inc. 8200 West Tower Avenue Milwaukee, WI 53223
Re: K980299 APEX Oximeter Regulatory Class: II (two) Product Code: 74 DQA Dated: January 26, 1998 Received: January 27, 1998
Dear Mr. Wahlig:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (25) --inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Mr. David Wahlig
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Thomas J. Callahan
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known):
Device Name: APEX Oximeter
Unknown;
y in
Indications For Use:
This device is viewed as a component of a system. The APEX Oximeter adds modularity to Marquette's CD Telemetry System product line. The Apex Oximeter is intended for portable patient monitoring of an ambulating patient's oxygen saturation and pulse rate.
This device is intended to be used by personnel trained in the use of the equipment. It is intended to be used within the hospital/facility environment.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Um. P
(Division Sign-Off) Division of Cardiovascular, Re and Neurological Device 510(k) Number
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use
(Optional Format 1-2-96)
000004